Published in Am J Physiol Heart Circ Physiol on January 28, 2011
Effects of varying degrees of intermittent hypoxia on proinflammatory cytokines and adipokines in rats and 3T3-L1 adipocytes. PLoS One (2014) 0.90
Vascular and hepatic impact of short-term intermittent hypoxia in a mouse model of metabolic syndrome. PLoS One (2015) 0.78
Leptin levels predict survival in pulmonary arterial hypertension. Pulm Circ (2012) 0.77
Uncoupling of Vascular Nitric Oxide Synthase Caused by Intermittent Hypoxia. Oxid Med Cell Longev (2016) 0.75
miR-181b regulates vascular stiffness age dependently in part by regulating TGF-β signaling. PLoS One (2017) 0.75
The impact of chronic intermittent hypoxia on hematopoiesis and the bone marrow microenvironment. Pflugers Arch (2016) 0.75
Killing Me Unsoftly: Causes and Mechanisms of Arterial Stiffness. Arterioscler Thromb Vasc Biol (2017) 0.75
Leptin-replacement therapy for lipodystrophy. N Engl J Med (2002) 7.78
Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med (2005) 3.73
Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ (2000) 3.60
Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation (2003) 3.30
Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension (1992) 3.14
Chronic leptin infusion increases arterial pressure. Hypertension (1998) 2.78
Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol (2003) 2.71
Leptin, the product of Ob gene, promotes angiogenesis. Circ Res (1998) 2.63
Serum leptin and vascular risk factors in obstructive sleep apnea. Chest (2000) 2.53
Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A (2004) 2.41
Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol (2007) 2.28
Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol Endocrinol Metab (2008) 2.28
Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6J mouse. Sleep Med (2005) 2.22
Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res (2005) 2.21
Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc Natl Acad Sci U S A (2008) 2.12
Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc Natl Acad Sci U S A (2000) 2.11
Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol (1985) (2005) 2.09
Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med (2007) 2.09
Method for isolation of adult mouse cardiac myocytes for studies of contraction and microfluorimetry. Am J Physiol (1996) 2.08
Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes (2002) 1.65
Hypertension caused by chronic intermittent hypoxia--influence of chemoreceptors and sympathetic nervous system. J Hypertens (1997) 1.62
Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase. Circ Res (2008) 1.61
Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice. J Appl Physiol (1985) (2005) 1.57
Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes (1999) 1.55
Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes (2000) 1.54
Dynamic arterial blood gas analysis in conscious, unrestrained C57BL/6J mice during exposure to intermittent hypoxia. J Appl Physiol (1985) (2008) 1.43
Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO. Hypertension (2000) 1.42
Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun (2006) 1.36
A new model of chronic intermittent hypoxia in humans: effect on ventilation, sleep, and blood pressure. J Appl Physiol (1985) (2009) 1.33
Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol (2008) 1.30
Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med (2007) 1.27
Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens (1996) 1.26
Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c. Diabetes (2006) 1.25
Obstructive sleep apnea and pulmonary hypertension. Prog Cardiovasc Dis (2009) 1.21
Mechanisms mediating renal sympathetic activation to leptin in obesity. Am J Physiol Regul Integr Comp Physiol (2008) 1.20
The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism. Endocrinology (2006) 1.16
Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice. J Appl Physiol (1985) (2000) 1.14
Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia. J Appl Physiol (1985) (2007) 1.07
Hyperleptinemia: protecting the heart from lipid overload. Hypertension (2005) 1.04
Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome. Intern Med (2008) 1.04
Human leptin induces angiogenesis in vivo. Cytokine (2008) 1.04
Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy. J Physiol (2005) 0.98
Intracerebroventricular leptin regulates hepatic cholesterol metabolism. Biochem J (2004) 0.96
Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein. Endocrinology (2009) 0.95
High-fat diet-induced obesity leads to resistance to leptin-induced cardiomyocyte contractile response. Obesity (Silver Spring) (2008) 0.92
Leptin is essential in maintaining normal vascular compliance independent of body weight. Int J Obes (Lond) (2009) 0.90
Autoadjusting-CPAP effect on serum leptin concentrations in obstructive sleep apnoea patients. BMC Pulm Med (2008) 0.85
Evidence that leptin contributes to intestinal cholesterol absorption in obese (ob/ob) mice and wild-type mice. Lipids (2002) 0.83
Vascular endothelial dysfunction in patients with mild obstructive sleep apnea syndrome. Wien Med Wochenschr (2006) 0.81
Leptin increases skeletal muscle lipoprotein lipase and postprandial lipid metabolism in mice. Metabolism (2010) 0.80
The potential beneficial effect of leptin on an experimental model of hyperlipidemia, induced by chronic ethanol treatment. Clin Chim Acta (2003) 0.78
Do measures of vascular compliance correlate with endothelial function? Curr Diab Rep (2007) 0.76
Pathophysiology of sleep apnea. Physiol Rev (2010) 4.69
Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature (2002) 3.92
Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation (2003) 3.30
Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res (2011) 2.94
Glucose infusion in mice: a new model to induce beta-cell replication. Diabetes (2007) 2.81
Disorders of glucose metabolism in sleep apnea. J Appl Physiol (1985) (2005) 2.78
Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol (2003) 2.71
Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res (2008) 2.70
Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med (2007) 2.63
Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med (2007) 2.62
Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res (2007) 2.62
Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res (2003) 2.44
Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ Res (2006) 2.42
Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol (1985) (2006) 2.39
Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension (2005) 2.37
Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration. Anesth Analg (2013) 2.29
Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol (2007) 2.28
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med (2015) 2.23
Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6J mouse. Sleep Med (2005) 2.22
Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res (2005) 2.21
Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol (1985) (2005) 2.09
Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med (2007) 2.09
Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy. Circ Res (2005) 2.05
Impaired red blood cell deformability after transfusion of stored allogeneic blood but not autologous salvaged blood in cardiac surgery patients. Anesth Analg (2014) 2.04
Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. Cardiovasc Res (2007) 2.01
Leptin signaling and obesity: cardiovascular consequences. Circ Res (2007) 1.95
Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci U S A (2004) 1.91
Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation. J Am Coll Cardiol (2011) 1.83
Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Am J Respir Crit Care Med (2008) 1.82
Apurinic/apyrimidinic endonuclease 1 regulates endothelial NO production and vascular tone. Circ Res (2004) 1.81
Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol (1985) (2009) 1.76
Trimetazidine: a meta-analysis of randomised controlled trials in heart failure. Heart (2010) 1.74
Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase. J Am Coll Cardiol (2012) 1.72
Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol (2013) 1.65
Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol (2003) 1.62
Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase. Circ Res (2008) 1.61
Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness. J Appl Physiol (1985) (2006) 1.59
Chronic intermittent hypoxia predisposes to liver injury. Hepatology (2007) 1.57
Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am J Physiol Renal Physiol (2005) 1.54
The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One (2010) 1.51
Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol (2006) 1.50
Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice. Exp Physiol (2008) 1.48
Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis (2009) 1.48
Microgravity-induced changes in aortic stiffness and their role in orthostatic intolerance. J Appl Physiol (1985) (2006) 1.46
A simplified method for measuring critical pressures during sleep in the clinical setting. Am J Respir Crit Care Med (2004) 1.45
A physiologic comparison of nasal and oral positive airway pressure. Chest (2003) 1.44
Critical role for the alpha-1B adrenergic receptor at the sympathetic neuroeffector junction. Hypertension (2004) 1.44
Dynamic arterial blood gas analysis in conscious, unrestrained C57BL/6J mice during exposure to intermittent hypoxia. J Appl Physiol (1985) (2008) 1.43
Hyperinsulinemia predicts survival in a hyperglycemic mouse model of critical illness. Crit Care Med (2009) 1.41
Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes. J Appl Physiol (1985) (2011) 1.41
Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha. Physiol Genomics (2006) 1.38
Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism. Proc Natl Acad Sci U S A (2006) 1.36
Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium. Circulation (2005) 1.35
Exercise protects against myocardial ischemia-reperfusion injury via stimulation of β(3)-adrenergic receptors and increased nitric oxide signaling: role of nitrite and nitrosothiols. Circ Res (2011) 1.35
Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract Res Clin Endocrinol Metab (2010) 1.34
Arginase and vascular aging. J Appl Physiol (1985) (2008) 1.33
Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice. PLoS One (2008) 1.32
Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring) (2011) 1.32
Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J Physiol (2007) 1.32
Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res (2005) 1.30
Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circ Res (2010) 1.30
Vascular stiffness and increased pulse pressure in the aging cardiovascular system. Cardiol Res Pract (2011) 1.28
Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes (2010) 1.27
Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor. J Mol Cell Cardiol (2009) 1.24
PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation. Basic Res Cardiol (2010) 1.21
Mitochondrial arginase II constrains endothelial NOS-3 activity. Am J Physiol Heart Circ Physiol (2007) 1.21
Free fatty acids block glucose-induced β-cell proliferation in mice by inducing cell cycle inhibitors p16 and p18. Diabetes (2012) 1.19
Intermittent hypoxia has organ-specific effects on oxidative stress. Am J Physiol Regul Integr Comp Physiol (2008) 1.19
Simultaneous measurement of insulin sensitivity, insulin secretion, and the disposition index in conscious unhandled mice. Obesity (Silver Spring) (2012) 1.17
Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans. Hypertension (2011) 1.15
Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea. Eur Heart J (2011) 1.14
Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries. Circ Res (2010) 1.13
OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling. Atherosclerosis (2010) 1.12